Our Highest Priority
Lead the Way
Meet or Exceed Expectaions
Your Team and Take the Risk
Luminex Corporation (NASDAQ: LMNX) was incorporated in May 1995 and began commercial production of our first generation system in 1997. Luminex develops, manufactures and markets innovative biological testing technologies with applications throughout the diagnostic and life science industries. The company’s open-architecture xMAP® and xTAG® Technologies enable large numbers of biological tests (bioassays) to be conducted and analyzed quickly, cost-effectively and accurately. Systems using xMAP technology perform discrete bioassays on the surface of color-coded beads known as microspheres, which are then read in a compact analyzer.
We are proud to have a strong, focused, and industry-leading management team. Read more about the team that drives Luminex’s core mission forward.
We enjoy an entrepreneurial fast-paced environment of highly motivated and creative individuals with a passion for innovation.
Learn what is happening and stay up to date by reading recent and past press releases, news, and current events.
In one comprehensive section, access investor information and find contact information.
As a result of the dynamic business model that we have created, our products are available for purchase through a well-established distribution network.
Our exclusive network of market-leading partners use our technology to create powerful, customizable kits on the xMAP platform.
We are committed to honest, open, and fair business conduct, and a culture dedicated to these principles.
We offer comprehensive and innovative technical support, training, and hands-on field training to optimize your experience with Luminex systems.